Search results
Results from the WOW.Com Content Network
Pharmacovigilance (PV, or PhV), also known as drug safety, is the pharmaceutical science relating to the "collection, detection, assessment, monitoring, and prevention" of adverse effects with pharmaceutical products. [1]: 7 The etymological roots for the word "pharmacovigilance" are: pharmakon (Greek for drug) and vigilare (Latin for to keep watch
However, scientific patient safety research by Annegret Hannawa, among others, has shown that ineffective communication has the opposite effect as it can lead to severe patient harm. [28] [29] [30] Communication regarding patient safety can be classified into two categories: prevention of adverse events and responding to adverse events ...
The Institute for Safe Medication Practices (ISMP) is an American 501(c)(3) organization focusing on the prevention of medication errors and promoting safe medication practices. [1] It is affiliated with ECRI .
In 1998, the textbook Pharmaceutical Care Practice: The Patient-Centered Approach to Medication Management was first published. [9] This included a definition of pharmaceutical care informed by the research of Drs. Robert Cipolle, Linda Strand, and Peter Morley that spanned 5 years and involved 20 different community pharmacy practice sites and ...
Goal 3: Improve the safety of high-alert medications. Goal 4: Ensure safe surgery. Goal 5: Reduce the risk of health care-associated infections. Goal 6: Reduce the risk of patient harm resulting from falls. [2] [4]
Medical ethics – System of moral principles of the practice of medicine; Pharmaceutical company – Industry involved with discovery, development, production and marketing of drugs; Pharmacovigilance – Drug safety; subdiscipline of pharmacy relating to prevention of adverse effects of drugs
Type A: augmented pharmacological effects, which are dose-dependent and predictable [5]; Type A reactions, which constitute approximately 80% of adverse drug reactions, are usually a consequence of the drug's primary pharmacological effect (e.g., bleeding when using the anticoagulant warfarin) or a low therapeutic index of the drug (e.g., nausea from digoxin), and they are therefore predictable.
The drug must be found to be effective against the disease for which it is seeking approval (where 'effective' means only that the drug performed better than placebo or competitors in at least two trials). The drug must meet safety criteria by being subject to animal and controlled human testing. Gaining FDA approval usually takes several years.